Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ezetimibe and Atorvastatin Calcium Tablets（Ⅱ）

Approval Number

国药准字H20253380

Company北京福元医药股份有限公司

Registration Date

February 11, 2025

Drug Information

Generic Name

依折麦布阿托伐他汀钙片(Ⅱ)

Dosage Form

片剂

Strength

每片含依折麦布10mg与阿托伐他汀钙20mg（按C₃₃H₃₅FN₂O₅计）

Drug Type

化学药品

Registration Date

February 11, 2025

Company Information

Applicant Company

Company Name北京福元医药股份有限公司

Company Address

北京市通州区通州工业开发区广源东街8号

Manufacturing Company

Company Name北京福元医药股份有限公司

Company Address

北京市通州区通州工业开发区广源东街8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy